Cargando…
Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
Triple-negative breast cancer (TNBC) is an aggressive breast type of cancer with no expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). It is a highly metastasized, heterogeneous disease that accounts for 10–15% of total breast cance...
Autores principales: | Dass, Sylvia Annabel, Tan, Kim Liu, Selva Rajan, Rehasri, Mokhtar, Noor Fatmawati, Mohd Adzmi, Elis Rosliza, Wan Abdul Rahman, Wan Faiziah, Tengku Din, Tengku Ahmad Damitri Al-Astani, Balakrishnan, Venugopal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826673/ https://www.ncbi.nlm.nih.gov/pubmed/33445543 http://dx.doi.org/10.3390/medicina57010062 |
Ejemplares similares
-
Rapamycin as a potent and selective inhibitor of vascular endothelial growth
factor receptor in breast carcinoma
por: Muhammad Sakri, Muhammad Shahidan, et al.
Publicado: (2022) -
The Unique Biology behind the Early Onset of Breast Cancer
por: Siddig, Alaa, et al.
Publicado: (2021) -
Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth
por: Jaffar, Nurul Fathiyatul Nabila, et al.
Publicado: (2020) -
High-Dose Vitamin C for Cancer Therapy
por: Mussa, Ali, et al.
Publicado: (2022) -
Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses
por: Siddig, Alaa, et al.
Publicado: (2023)